MyFinsight
Home
Blog
About
Proceeds of available for
sale securities
$13,068K
Proceeds from maturity of
certificates of deposit
$2,924K
(-73.87%↓ Y/Y)
Proceeds from sale of
equipment
$7K
(-63.16%↓ Y/Y)
Net cash provided by
investing activities
$9,757K
(1007.63%↑ Y/Y)
Effect of exchange rate
changes on cash
$643K
(549.49%↑ Y/Y)
Canceled cashflow
$6,242K
Net (decrease)
increase in cash
-$6,336K
(-125.67%↓ Y/Y)
Canceled cashflow
$10,400K
Due to related
parties
$4,800K
Notes receivable
-$3,472K
(10.49%↑ Y/Y)
Prepaid and other assets
-$2,977K
(-3233.68%↓ Y/Y)
Stock-based compensation
$2,075K
(46.85%↑ Y/Y)
Depreciation and
amortization
$1,483K
(26.11%↑ Y/Y)
Noncash lease expense
$224K
(-44.00%↓ Y/Y)
Inventories
-$94K
(-103.77%↓ Y/Y)
Foreign currency
exchange gain
-$39K
Equity in loss of
unconsolidated affiliate
-$22K
(42.11%↑ Y/Y)
Loss on disposal of
property and equipment
-$2K
(-100.00%↓ Y/Y)
Proceeds from the
exercise of stock options
$200K
(-89.94%↓ Y/Y)
Purchase of certificates
of deposit
$2,924K
(-73.86%↓ Y/Y)
Purchase of available for
sale securities
$2,032K
Acquisition of intangible
assets
$1,024K
(41.83%↑ Y/Y)
Purchase of property and
equipment
$262K
(-30.69%↓ Y/Y)
Net cash used in
operating activities
-$16,728K
(-953.91%↓ Y/Y)
Canceled cashflow
$15,188K
Net cash provided by
financing activities
-$8K
(-100.03%↓ Y/Y)
Canceled cashflow
$200K
Net (loss) income
-$22,991K
(-532.98%↓ Y/Y)
Accounts receivable
$4,473K
Deferred income taxes,
net
-$1,426K
(-190.43%↓ Y/Y)
Income tax payable
-$1,021K
(41.76%↑ Y/Y)
Accrued interest on
long-term certificates of...
$542K
Operating lease
liabilities
-$536K
(-97.06%↓ Y/Y)
Accrued expenses and
other liabilities
-$502K
(-124.15%↓ Y/Y)
Accounts payable
-$249K
(-572.97%↓ Y/Y)
Change in fair value of
financial liabilities,...
$220K
Payments of listing
expense
$208K
Back
Back
Cash Flow
GYRE THERAPEUTICS, INC. (GYRE)
GYRE THERAPEUTICS, INC. (GYRE)
source: myfinsight.com